Log in
Enquire now
‌

US Patent 11912778 Methods of engineering transferrin receptor binding polypeptides

Patent 11912778 was granted and assigned to Denali Therapeutics on February, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Denali Therapeutics
Denali Therapeutics
0
Date Filed
August 15, 2022
0
Date of Patent
February 27, 2024
0
Patent Applicant
Denali Therapeutics
Denali Therapeutics
0
Patent Application Number
17888406
0
Patent Citations
‌
US Patent 8053567 Modified surface material, method for preparing same and uses thereof
0
‌
US Patent 8084254 Human blood brain barrier model
0
‌
US Patent 8088376 Fc variants with altered binding to FcRn
0
‌
US Patent 7241449 Transferrin receptor genes of
0
‌
US Patent 7371826 Polypeptide variants with altered effector function
0
‌
US Patent 7670600 Molecules with extended half-lives, compositions and uses thereof
0
‌
US Patent 7741446 Fusion antibodies that cross the blood-brain barrier in both directions
0
‌
US Patent 7744879 Blood-brain barrier targeting antibodies
0
‌
US Patent 10323089 Anti-transferrin receptor antibodies with tailored affinity
0
‌
US Patent 10364292 Monovalent blood brain barrier shuttle modules
0
•••
Patent Inventor Names
Mark S. Dennis
0
Joy Yu Zuchero
0
Ankita Srivastava
0
Mihalis Kariolis
0
Ryan J. Watts
0
Adam P. Silverman
0
Robert C. Wells
0
Xiaocheng Chen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11912778
0
Patent Primary Examiner
‌
Christian C Boesen
0

Find more entities like US Patent 11912778 Methods of engineering transferrin receptor binding polypeptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.